Health Care Equipment & Supplies · NYSE

ABTAbbott Laboratories

Last close
$108.52 +1.2%
52-week range
$81.97 to $132.03
Market cap
$188B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$44.3B
+6% vs FY24
Net income
$6.52B
-51% vs FY24
Free cash flow
$7.39B
+16% vs FY24
Net cash
-$3.99B
Cash $8.94B, debt $12.9B

Stock price

+177% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on 3 of 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
40.4x
14.7x240x
60th percentile, above its median of 36.2x
Price / sales
3.9x
2.7x6.0x
25th percentile, below its median of 4.7x
EV / EBITDA
26.1x
15.8x45.5x
45th percentile, below its median of 27.1x
Price / free cash flow
27.8x
20.0x42.4x
45th percentile, below its median of 28.7x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
40.4x
Earnings yield
2.5%
Price / sales
3.9x
Price / book
3.7x
Price / operating cash flow
21.2x
EV / EBITDA
26.1x
EV / sales
4.5x
Free cash flow yield
3.6%

Profitability

Gross margin
56.9%
Operating margin
13.8%
Net margin
9.7%
Return on equity
9.2%
Return on capital
5.8%

Growth per year

Revenue, 3 years
+0.5%
Revenue, 5 years
+5.1%
Revenue, 9 years
+8.7%
EPS, 3 years
-1.6%

Balance sheet

Cash and investments
$4.30B
Total debt
$31.2B
Net cash
-$26.9B
Debt / equity
0.61x
Current ratio
1.45x

Shares and dividend

Shares outstanding
1.73B
Share count, 5 years
-2.1%
Beta, 1 year
0.07
Dividend yield
2.3%
Dividend per share, TTM
$2.52
Payout ratio
92.0%

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $13.0B
RevenueNet income
Gross profitLatest quarter $7.38B
EBITDALatest quarter $1.77B
Margins57 / 10 / 7%
GrossOperatingNet
Earnings per shareLatest quarter $0.53
Cash flowLatest quarter $1.74B
OperatingCapexFree
Cash vs debtLatest quarter $4.30B
Cash and investmentsTotal debt
P/E historyNow 40.4x
P/E, median 36.2x dashed
P/S historyNow 3.9x
P/S, median 4.7x dashed

Where the revenue comes from

US went from 42% to 39% of revenue in 3 years

Share of revenue by region, fiscal 2022 to 2025, as reported in the 10-K.

USAll Other CountriesDECNCHINOther
FY22
42%34%
$43.7B
FY23
39%35%
$40.1B
FY24
39%35%
$42.0B
FY25
39%36%
$44.3B
Fiscal 2025 by region
RegionRevenueSharevs FY24
US$17.1B38.6%+5%
All Other Countries$16.0B36.0%+8%
DE$2.76B6.2%+9%
CN$1.91B4.3%-10%
CH$1.87B4.2%+7%
IN$1.87B4.2%+3%
Other$2.81B6.4%+7%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
BSX Boston Scientific Corp $64.3B +9% 18.7%18.8x3.1x 22nd percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
CEO
Miles D. White
Employees
73,000 (as of 2015)
Founded
1888
Headquarters
Abbott Park, IL
Fiscal year ends
December
Website
abbott.com

What it does

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about ABT.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 2,655 active funds. Crowd level: quiet.

Open the Smart money tab